Table of Contents

2019-2024 Global P2X7 Receptor Antagonists Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global P2X7 Receptor Antagonists Market Size 2014-2024
  • 2.1.2 P2X7 Receptor Antagonists Market Size CAGR by Region
• 2.2 P2X7 Receptor Antagonists Segment by Type
  • 2.2.1 GSK1482160
  • 2.2.2 AZD9056
  • 2.2.3 EVT 401
  • 2.2.4 JNJ 55308942 & JNJ 54175446
  • 2.2.5 AKP-23494954/RQ-00466479
  • 2.2.6 Others
• 2.3 P2X7 Receptor Antagonists Market Size by Type
  • 2.3.1 Global P2X7 Receptor Antagonists Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (2014-2019)
• 2.4 P2X7 Receptor Antagonists Segment by Application
  • 2.4.1 Inflammatory Diseases
  • 2.4.2 Central Nervous System Diseases
  • 2.4.3 Immune System Disorders
• 2.5 P2X7 Receptor Antagonists Market Size by Application
  • 2.5.1 Global P2X7 Receptor Antagonists Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global P2X7 Receptor Antagonists Market Size Growth Rate by Application (2014-2019)

3 Global P2X7 Receptor Antagonists by Players

• 3.1 Global P2X7 Receptor Antagonists Market Size Market Share by Players
  • 3.1.1 Global P2X7 Receptor Antagonists Market Size by Players (2017-2019)
  • 3.1.2 Global P2X7 Receptor Antagonists Market Size Market Share by Players (2017-2019)
• 3.2 Global P2X7 Receptor Antagonists Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 P2X7 Receptor Antagonists by Regions

• 4.1 P2X7 Receptor Antagonists Market Size by Regions
• 4.2 Americas P2X7 Receptor Antagonists Market Size Growth
• 4.3 APAC P2X7 Receptor Antagonists Market Size Growth
• 4.4 Europe P2X7 Receptor Antagonists Market Size Growth
• 4.5 Middle East & Africa P2X7 Receptor Antagonists Market Size Growth

5 Americas

• 5.1 Americas P2X7 Receptor Antagonists Market Size by Countries
• 5.2 Americas P2X7 Receptor Antagonists Market Size by Type
• 5.3 Americas P2X7 Receptor Antagonists Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC P2X7 Receptor Antagonists Market Size by Countries
• 6.2 APAC P2X7 Receptor Antagonists Market Size by Type
• 6.3 APAC P2X7 Receptor Antagonists Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe P2X7 Receptor Antagonists by Countries
• 7.2 Europe P2X7 Receptor Antagonists Market Size by Type
• 7.3 Europe P2X7 Receptor Antagonists Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa P2X7 Receptor Antagonists by Countries
• 8.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type
• 8.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global P2X7 Receptor Antagonists Market Forecast

• 10.1 Global P2X7 Receptor Antagonists Market Size Forecast (2019-2024)
• 10.2 Global P2X7 Receptor Antagonists Forecast by Regions
  • 10.2.1 Global P2X7 Receptor Antagonists Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global P2X7 Receptor Antagonists Forecast by Type
• 10.8 Global P2X7 Receptor Antagonists Forecast by Application

11 Key Players Analysis

• 11.1 GlaxoSmithKline
  • 11.1.1 Company Details
  • 11.1.2 P2X7 Receptor Antagonists Product Offered
  • 11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 GlaxoSmithKline News
• 11.2 AstraZeneca
  • 11.2.1 Company Details
  • 11.2.2 P2X7 Receptor Antagonists Product Offered
  • 11.2.3 AstraZeneca P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 AstraZeneca News
• 11.3 Janssen
  • 11.3.1 Company Details
  • 11.3.2 P2X7 Receptor Antagonists Product Offered
  • 11.3.3 Janssen P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Janssen News
• 11.4 RaQualia Pharma
  • 11.4.1 Company Details
  • 11.4.2 P2X7 Receptor Antagonists Product Offered
  • 11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 RaQualia Pharma News
• 11.5 Evotec
  • 11.5.1 Company Details
  • 11.5.2 P2X7 Receptor Antagonists Product Offered
  • 11.5.3 Evotec P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Evotec News
• 11.6 Asahi Kasei Pharma
  • 11.6.1 Company Details
  • 11.6.2 P2X7 Receptor Antagonists Product Offered
  • 11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Asahi Kasei Pharma News
• 11.7 Pfizer
  • 11.7.1 Company Details
  • 11.7.2 P2X7 Receptor Antagonists Product Offered
  • 11.7.3 Pfizer P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Pfizer News

...

12 Research Findings and Conclusion

P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.

According to this study, over the next five years the P2X7 Receptor Antagonists market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in P2X7 Receptor Antagonists business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of P2X7 Receptor Antagonists market by product type, application, key companies and key regions.

This study considers the P2X7 Receptor Antagonists value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
GSK1482160
AZD9056
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global P2X7 Receptor Antagonists market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of P2X7 Receptor Antagonists market by identifying its various subsegments.
Focuses on the key global P2X7 Receptor Antagonists players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the P2X7 Receptor Antagonists with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of P2X7 Receptor Antagonists submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.